Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?

Ali, Nurshad

Ali, Nurshad.

Ali N; Department of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet 3114, Bangladesh. Electronic address: nur_rubd@yahoo.com.

Clin Res Hepatol Gastroenterol ; 44(4): e84-e86, 2020 09.

Article in English | MEDLINE | ID: covidwho-423027

Subject(s)

Betacoronavirus; Coronavirus Infections/complications; Liver Diseases/etiology; Pneumonia, Viral/complications; Alanine Transaminase/blood; Angiotensin-Converting Enzyme 2; Antiviral Agents/adverse effects; Aspartate Aminotransferases/blood; COVID-19; Coronavirus Infections/drug therapy; Humans; Liver Diseases/enzymology; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral/drug therapy; Risk Factors; SARS-CoV-2; gamma-Glutamyltransferase/blood; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus / Liver Diseases Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Clin Res Hepatol Gastroenterol Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google